Allotment of 40,000 Equity Shares to Promoter upon conversion of Warrants into Equity Shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals has allotted 40,000 equity shares to its promoter, Mrs. Daulat Nariman Medhora, upon conversion of convertible warrants. The shares were issued at ₹1,250 each (face value ₹10 plus premium of ₹1,240), totaling ₹3.75 crore. The warrants were originally allotted on December 29, 2025, with 25% paid upfront (₹312.50 per warrant) and the remaining 75% (₹937.50 per warrant) paid before conversion. All 40,000 warrants have been fully converted with no outstanding warrants remaining. The new shares will rank equally with existing equity shares.
Promoter holding will increase as warrants held by the promoter have been converted to equity, signaling promoter confidence in the company. The stock's fully diluted share count has increased by 40,000 shares.